Middle East and Africa Gene Expression Market Report and Forecast 2025-2034

Middle East and Africa Gene Expression Market Size

The global gene expression market was valued at USD 13.3 billion in 2024, with the Middle East and Africa holding a significant market share. The market is driven by the increased government initiatives and funding in genomic research. It is expected to grow at a CAGR of 10.42% during the forecast period of 2025-2034, with the values likely to attain USD 32.4 billion by 2034.

Middle East and Africa Gene Expression Market Outlook

• Recent data reveals that around 22,000 people in Saudi Arabia die from the four main non-communicable diseases every year, accounting for 35% of all deaths in the Kingdom of Saudi Arabia. This rising disease burden is likely to augment the demand for gene expression tools and services.

• One of the major Middle East and Africa gene expression market trends is the increased government initiatives and funding to stimulate research and innovation in the genomics sector. In January 2024, the Saudi Arabian government launched the National Biotech Strategy, intending to give the highest priority to genomics, among 4 other cutting-edge areas.

• The market share is also impacted by the rising healthcare expenditure, which often leads to increased funding for genomics and gene expression studies. For instance, under Vision 2030, the Saudi Arabian government is planning to invest more than USD 65 billion towards the development of the country’s healthcare infrastructure and health services.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Middle East and Africa Gene Expression Market Analysis

The market involves the analysis, manipulation, or measurement of gene expression patterns within cells or tissues. It comprises a range of products, technologies, and services aimed at studying gene expression. Several pharmaceutical and biotechnology companies are increasingly utilizing gene expression analysis in biomarker identification and drug discovery to develop novel drugs. Moreover, the growing demand for personalized medicine and targeted therapies is expected to drive the Middle East and Africa gene expression market growth in the forecast period.

The market Is also influenced by the increasing burden of non-communicable diseases in the region, which takes a significant toll on mortality and morbidity. Recent data reveals that around 22,000 people in Saudi Arabia die from the four main non-communicable diseases (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) every year, accounting for 35% of all deaths in the Kingdom of Saudi Arabia. Additionally, more than 1 in 4 people are suffering from one of the 4 main non-communicable diseases, indicating the need for effective treatment options. Gene expression analysis is integral to understanding disease progression, prognosis, and treatment response as well as plays a key role in drug discovery and development. Consequently, the rising disease burden is likely to augment the Middle East and Africa gene expression market demand.

One of the major market trends is the increased government initiatives and fundings to stimulate research and innovation in the genomics sector. In January 2024, the Saudi Arabian government launched the National Biotech Strategy as part of the project Vision 2030, with the aim to make the Kingdom of Saudi Arabia a leading biotech hub in the Middle East and Africa by 2030 and a global biotech leader by 2040. The strategy plans to give the highest priority to genomics, among 4 other cutting-edge areas, to fuel genomic research and foster advancement in precision and individualized medicine. Such rigorous government support is anticipated to boost the Middle East and Africa gene expression market share.

The market is also impacted by the rising healthcare expenditure, which often leads to increased funding for biomedical research, including genomics and gene expression studies. For instance, under Vision 2030, the Saudi Arabian government is planning to invest more than USD 65 billion towards the development of the country’s healthcare infrastructure and health services. Such substantial investments are poised to elevate the market value in the coming years. Further, the rising foreign investment in the region by the leading market players is expected to accelerate the market growth.

Middle East and Africa Gene Expression Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Leading Players in the Middle East and Africa Gene Expression Market

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific Inc.

• Bio-Rad Laboratories

• Illumina, Inc.

• QIAGEN

• F. Hoffmann-La Roche Ltd.

• REVVITY

• PacBio

• Agilent Technologies, Inc.

• Sysmex Corporation

• BGI

• Eurofins Scientific SE

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Our Top Selling Reports

Thrombin Market

Cytokine Market

Dialyzer Market

Anoscope Market

Alopecia Market

Genomics Market

Catheter Market

Dyspepsia Market

Burn Pain Market

Exanthema Market

Middle East and Africa Gene Expression Market Report Snapshots

Middle East and Africa Gene Expression Market Size

Middle East and Africa Gene Expression Market Analysis

Middle East and Africa Gene Expression Companies